Sale of 23,463 shares at $7.1977 per share.
Reporting Person Aslan Fred · Officer Title Chief Executive Officer · Transaction Code S
Traded Oct 6, 2026 · Disclosed Oct 7, 2026
Source: SEC Form 4 · 0001193125-26-416953 · filed 2026-10-07 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Artiva Biotherapeutics, Inc. (ARTV)." Disclosed 2026-10-07. https://desqlong.com/cards/0001193125-26-416953-1 (retrieved 2026-10-08).